- Home
- AGL
as 06-04-2025 4:00pm EST
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 968.6M | IPO Year: | 2021 |
| Target Price: | $4.47 | AVG Volume (30 days): | 5.4M |
| Analyst Decision: | Hold | Number of Analysts: | 20 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.59 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.50 - $7.73 | Next Earning Date: | 05-06-2025 |
| Revenue: | $5,988,958,000 | Revenue Growth: | 23.07% |
| Revenue Growth (this year): | -0.82% | Revenue Growth (next year): | 10.11% |
Latest agilon health inc. News
AGL Breaking Stock News: Dive into AGL Ticker-Specific Updates for Smart Investing
Business Wire
16 days ago
agilon health to Participate in Bernstein's 41st Annual Strategic Decisions Conference
StockStory
17 days ago
AGL Q1 Earnings Call: Membership Declines, Technology Investments, and Cautious Outlook for 2025
Simply Wall St.
a month ago
agilon health First Quarter 2025 Earnings: Beats Expectations
StockStory
a month ago
Why agilon health (AGL) Stock Is Nosediving
GuruFocus.com
a month ago
Agilon Health Inc (AGL) Q1 2025 Earnings Call Highlights: Navigating Challenges and Optimizing ...
Zacks
a month ago
Agilon Health (AGL) Reports Break-Even Earnings for Q1
StockStory
a month ago
agilon health (NYSE:AGL) Beats Q1 Sales Targets
Business Wire
a month ago
agilon health Reports First Quarter 2025 Results
Compare AGL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AGL agilon health inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.